CAR T Therapy Dramatically Reduces Risk Of Relapse For Multiple Myeloma

A CAR T therapy produced by J&J and Legend Biotech significantly reduces risk of relapse for multiple myeloma patients who have received one to three previous lines of treatment, according to early study results.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Tags: Healthcare /healthcare Innovation /innovation business pharma & standard Source Type: news